|1.||Donald, Peter R: 4 articles (09/2015 - 04/2014)|
|2.||Zheng, Wei: 4 articles (10/2011 - 06/2006)|
|3.||Diacon, Andreas H: 3 articles (09/2015 - 10/2014)|
|4.||Jiang, Wendy: 3 articles (10/2011 - 03/2009)|
|5.||Jiang, Yue-Ming: 3 articles (08/2011 - 06/2006)|
|6.||Baughn, Anthony D: 2 articles (09/2015 - 01/2014)|
|7.||Turman, Breanna J: 2 articles (09/2015 - 01/2014)|
|8.||Rosenkranz, Bernd: 2 articles (07/2015 - 10/2014)|
|9.||Sy, Sherwin K B: 2 articles (07/2015 - 10/2014)|
|10.||de Kock, Lizanne: 2 articles (07/2015 - 10/2014)|
08/01/1994 - "4-Aminosalicylic acid (4-ASA) has been suggested as an effective treatment for both active and quiescent ulcerative colitis. "
09/25/2003 - "Aminosalicylic acid has a well-documented efficacy in the acute treatment of mild and moderate ulcerative colitis as well as in maintaining remission in these patients. "
02/01/1997 - "A six-week placebo-controlled trial of the efficacy and safety of 6 g per day of 4-aminosalicylic acid (4-ASA) was conducted in 30 subjects with mild to moderately severe ulcerative colitis. "
02/01/1992 - "Placebo-controlled trial of ulcerative colitis with oral 4-aminosalicylic acid."
05/01/2004 - "4-aminosalicylic acid (4-ASA) differs from its 5-ASA counterpart by the position of the NH2 group and has shown efficacy in ulcerative colitis. "
07/01/2015 - "The aim of this study was to examine the relationships between N-acetyltransferase genotypes, pharmacokinetics, and tolerability of granular slow-release para-aminosalicylic acid (GSR-PAS) in tuberculosis patients. "
02/01/2012 - "tuberculosis p-aminosalicylic acid resistance, and show by complementation studies that ThyA T202A and V261G appear to be functional and non-functional, respectively."
08/01/1964 - "[STUDIES ON THE DOSAGE OF P-AMINOSALICYLIC ACID IN THE TREATMENT OF TUBERCULOSIS]."
09/11/1954 - "Study of para-aminosalicylic acid intolerance in tuberculosis of lung."
09/04/1950 - "[Para-aminosalicylic acid therapy of tuberculosis of the urinary tract; clinical and bacteriological study]."
09/01/1960 - "[Histomorphological study of the gastric mucosa obtained by transoral biopsy in patients with pulmonary tuberculosis treated with unique dose of p-aminosalicylic acid]."
05/01/1955 - "[Clinical study of the effects of p-aminosalicylic acid hydrazide (pasdrazide) in some forms of pulmonary and extra-pulmonary tuberculosis]."
06/01/1949 - "Clinical study of the use of para-aminosalicylic acid in the treatment of pulmonary tuberculosis."
07/01/2015 - "N-acetyltransferase genotypes and the pharmacokinetics and tolerability of para-aminosalicylic acid in patients with drug-resistant pulmonary tuberculosis."
05/01/2009 - "We investigated signaling pathways regulating macrophage MMP-1 and -7 in human pulmonary tuberculosis and examine the hypothesis that the antimycobacterial drug p-aminosalicylic acid acts by inhibiting such pathways. "
|4.||Parkinsonian Disorders (Parkinsonism)
06/01/2006 - "We report a 17-year follow-up study of effective treatment of occupational Mn parkinsonism with sodium para-aminosalicylic acid (PAS). "
06/01/2006 - "Effective treatment of manganese-induced occupational Parkinsonism with p-aminosalicylic acid: a case of 17-year follow-up study."
04/05/2011 - "Para-aminosalicylic acid (PAS), an approved drug for treatment of tuberculosis, is a promising therapeutic agent for treatment of manganese (Mn)-induced parkinsonian syndromes. "
10/01/2011 - "para-aminosalicylic acid (PAS; 4-amino-2-hydroxybenzoic acid), an antituberculosis drug in use since the 1950s, has recently been suggested to be an effective agent for treatment of manganese-induced parkinsonian disorders. "
03/01/2009 - "Para-aminosalicylic acid (PAS), an FDA-approved anti-tuberculosis drug, has been used successfully in the treatment of severe manganese (Mn)-induced Parkinsonism in humans [Jiang Y-M, Mo X-A, Du FQ, Fu X, Zhu X-Y, Gao H-Y, et al. Effective treatment of manganese-induced occupational Parkinsonism with p-aminosalicylic acid: a case of 17-year follow-up study. "
04/01/1951 - "[Para-aminosalicylic acid and its medicamentous associations in tuberculous infection]."
07/01/1950 - "[Experience with p-aminosalicylic acid in treatment of tuberculous infections of the eye]."
01/30/1951 - "[Para-aminosalicylic acid in the treatment of primary tuberculosis infections in the young child]."
01/01/2013 - "The use of aminosalicylic acid, corticosteroid, immunosuppressants, pancolitis and severe IBD patients seemed to be more susceptible to CMV infection in univariate analysis of risk factors. "
12/01/1972 - "Rifampin has been studied in 68 patients and results can be summarized as follows:* There has been no evidence of significant toxicity.* In a randomized study of active tuberculosis patients who had not received prior chemotherapy, isoniazid-rifampin and isoniazid-aminosalicylic acid regiments were equally effective.* In retreatment patients with active, positive tuberculosis, the regimen of isoniazid, rifampin, and ethambutol proved to be very effective, especially when the two latter drugs had not been used previously.* In patients with pulmonary infections caused by atypical acid-fast bacilli, results varied with the organism isolated and the extent of disease. "
|2.||Streptomycin (Streptomycin Sulfate)
|4.||Aminosalicylic Acid (Rezipas)
|9.||Salicylic Acid (2 Hydroxybenzoic Acid)
|10.||Arachidonate 5-Lipoxygenase (5 Lipoxygenase)
|2.||Drug Therapy (Chemotherapy)